Hypothesis: Alpha-1-antitrypsin is a promising treatment option for COVID-19-Reference-Cited by-同舟云学术

Hypothesis: Alpha-1-antitrypsin is a promising treatment option for COVID-19

Published:2021-01 Issue: Volume:146 Page:110394
ISSN:0306-9877
Container-title:Medical Hypotheses
language:en
Short-container-title:Medical Hypotheses

Author:

Bai Xiyuan,Hippensteel Joseph,Leavitt Alida,Maloney James P.,Beckham David,Garcia Cindy,Li Qing,Freed Brian M.,Ordway Diane,Sandhaus Robert A.,Chan Edward D.

Publisher

Elsevier BV

Subject

General Medicine

Reference87 articles.

1. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study;Zhou;Lancet,2020

2. Dexamethasone in the management of covid-19: Preliminary trial results are mostly good news, but timing is everything;Johnson;BMJ,2020

3. China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China;Guan;N Engl J Med,2020

4. Cardiovascular complications in COVID-19;Long;Am J Emerg Med,2020

5. Middleton EA, He X-Y, Denorme F, et al. Neutrophil Extracellular Traps (NETs) Contribute to Immunothrombosis in COVID-19 Acute Respiratory Distress Syndrome. Blood 2020; Online ahead of print.

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunological and homeostatic pathways of alpha -1 antitrypsin: a new therapeutic potential;Frontiers in Immunology;2024-08-19

2. Aprotinin (I): Understanding the Role of Host Proteases in COVID-19 and the Importance of Pharmacologically Regulating Their Function;International Journal of Molecular Sciences;2024-07-10

3. Analysis of alpha‐1‐antitrypsin (AAT)‐regulated, glucocorticoid receptor‐dependent genes in macrophages reveals a novel host defense function of AAT;Physiological Reports;2024-07

4. Neutrophil-Derived Proteases in Lung Inflammation: Old Players and New Prospects;International Journal of Molecular Sciences;2024-05-17

5. Análisis de la expresión del gen SERPINA1 en la infección por SARS-CoV-2: estudio de un nuevo biomarcador;Revista Clínica Española;2024-05